Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Share News (CMH)

  • This share is currently suspended. It was suspended at a price of 1.18

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.18
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.18
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps: Titon, Utd Drug, Vernalis...

Thu, 29th Jul 2010 14:16

Blinds specialist Titon's revenues for the 3 months to June were 19% higher than the corresponding period last year, with UK sales 15% higher and the rest of the world 37% higher. Growth in the UK came from higher sales of mechanical ventilation systems. There were also increased sales volumes in South Korea. With 80% of sales emanating in the UK and with most other export markets showing little sign of recovery from the recession, Titon remains cautious about the short-term outlook.United Drug reports trading since April has been satisfactory, with a strong performance in parts of the business. Group profits for the nine months to 30 June were in line with last year, as expected, and cash flows continue to be strong throughout the group. Based on trading for the year to date, profits before tax for the year to 30 September should be broadly in line with last year.Drug developer Vernalis upped first half revenue by 26% to £7.2m (2009: £5.7m), with its operating loss reduced to £1.1m from £5.3m. Underlying cash burn reduced to £2.7m (2009: £8.2m).Stockbroker Charles Stanley grew revenue by 11.2% to £28.9m in its first quarter, although total client funds under investment management and administration fell 4.7% to £12.2bn in the three months ended 30 June.The update was accompanied by news that finance director Peter Hurst is hanging up his boots after 24 years in the same job. He'll retire some time in the middle of next year. Engineer Chamberlin has kept its strong run going after confirming first quarter business has been strong across all three of its foundries."With the improving demand, a reduced cost base and production capability intact, the board continues to be confident of a return to profitability in the year and views prospects very positively," chairman Tom Brown said in his AGM statement.Stockbroker Collins Stewart had a "solid" first half, although operating profit fell 8% at the wealth management business after a £0.5m one-off cost linked to acquisitions.Overall operating profit rose 20% to £7.3m on revenue £0.8m higher at £96.1m. Profit before tax added 7% to £6.5m, while assets under management have risen 15% since the end of 2009 to £6.8bn."The group has been turned around and is generally making progress in difficult markets," said boss Mark Brown. "The full benefits of previous investment are still to come through and our strong financial position will enable us to continue to invest as opportunities arise."Getech, a provider of geological data to assist with oil exploration, has continued the trend towards recovery during the second half of its current financial year.The first half loss of £392,000 will result in a deficit for the full-year, although there's likely to be an operating profit for the six months to 31 July. Production was down 17% at 30,236 ounces at gold miner Centamin Egypt between the fourth and third quarters due to lower-than-expected grade, although full-year guidance is kept at 200,000 ounces.Analysts at Ambrian are still backing the shares. They say all price drivers remain fully intact and strongly recommend buying into any weakness, although a further drop in production against forecast could create price pressure.Stem cell group Epistem reports strong growth in all divisions and in net profits, and says full-year results will be in line with forecasts. KBC Peel Hunt is happy with the update. The broker sees several near term catalysts, so keeps its 'buy' rating and 515p target price. More news on the collaboration with Novartis could provide scope for an upgrade, it says.A focus on internal efficiencies ensured cake and bread supplier Finsbury Food delivered profit in line with expectations despite a 9.7% decline in like for like sales at the cake division.The firm blamed a 4.1% drop in revenue to £168.3m on consumers trading down and more frequently choosing products on promotion.Panmure Gordon still thinks investors should tuck in. It's reassured by a rephrasing of £5m of deferred consideration, which eases pressure on cash flow, and confirmation that the group is operating fully within existing banking facilities. It keeps a 'buy' recommendation and 30p target price.The share price of sweets and cakes maker Lees Foods surged to a 52-week high after it said demand for its products continues to be strong, with both Lees of Scotland and The Waverley Bakery achieved record sales for the first half of the year.Pre-tax profits for the first six months of 2010 are set to be significantly ahead of last year, while group sales have risen to £9.62m from £8.85m the year before. The company remains cautiously optimistic in respect of the second half of the year and expects that both sales and pre-tax profits will be ahead of market forecasts for the full year.Interactive gaming company NetplayTV said a new format and schedule of its Challenge Jackpot and Bingo Stars offerings on ITV are scheduled to go live tonight (Thursday), which the company hopes will ginger up the response, which has thus far been disappointing.The company's core Supercasino.com business has seen improved depositing sign ups over the last month, as well as an increase in player numbers month on month, as a result of renewed focus on this brand. "We have however been impacted by a number of large winners reducing the gaming margin for July to 1.3% against an average for the year of 3%," the company said.
More News
24 Nov 2010 12:12

Chamberlin back in profit as recovery continues

Shares in Chamberlin, which makes metal products such as door handles and steering wheel components, moved higher after it returned to profit in the six months to September 30 as sales moved back towards pre-economic crisis levels. The company posted a pre-tax profit of £91,000 for the period, agai

Read more
29 Jul 2010 07:45

Chamberlin Sees Return To FY Profit

LONDON (Dow Jones)--Chamberlin PLC (CMH.LN), a specialist engineering group, said Thursday it trading in the first quarter of fiscal 2011 has remained strong across all three of its foundries, and said it expects to return to profit for the full year. MAIN FACTS: -Co. seeing the benefits of

Read more
28 Jun 2010 16:33

Non-exec's firm cashes in at Lancashire

Lancashire Holdings non-executive director Barry Volpert is chief executive of private equity firm Crestview, which has raised more than £4.7m from the sale of shares in the property, aviation and marine insurer. The share prices of the five separate disposals varied from 497p to just over 500p. C

Read more
10 Jun 2010 09:08

Chamberlin Swings Into FY10 Loss, Sees Return To Profit FY11

LONDON (Dow Jones)--Chamberlin PLC (CMH.LN), a foundry and engineering group, Thursday reported a swing into loss for fiscal 2010 but it expects to return to profitability in the new financial year, adding that it plans to return to paying dividends once conditions improve. MAIN FACTS: -Reve

Read more
27 Nov 2009 08:16

Stablisation seen at Chamberlin after tough half year

Foundry and engineering firm Chamberlin dived into the red at the interim stage but is confident of a better second half. Loss before tax and exceptional items for the six months to end-September was £0.48m, versus a profit of £1.21m (restated) a year earlier. With exceptional items included the l

Read more
23 Oct 2009 14:13

Small caps round-up: Molins, Abbeycrest, Agriterra, Chamberlin

Cigarette vending machine maker Molins does not seem to be suffering unduly from the effects of the smoking ban in the UK, with trading since the company's interim results announcement in late August remaining in line with expectations. Performance in the Tobacco Machinery and Scientific Services d

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.